Company Information
| Company name | Aptahem AB |
| Business strategy | Aptahem AB is a biotechnology company that develops RNA-based pharmaceuticals for the treatment of acute, life-threatening conditions in which a combination of coagulation, inflammation and tissue damage are involved. The company also performs business development activities to identify future collaboration partners and licensing partners. The company’s lead candidate Apta-1 is being developed as an emergency medicine intended to prevent the onset of life-threatening organ and tissue damage in sepsis patients. |
| CEO | Mikael Lindstam |
| Chairman of the Board | Bert Junno |
| Board | Bert Junno, Theresa Comiskey Olsen, Mikael Lindstam |
| Personell | 4 |
| Organisation number | 556970-5782 |
| Articles of Association | Articles of Association 2025-06-25. See link below to download (in Swedish). |
| Address | Norra Vallgatan 58 |
| Zip code | 211 22 |
| City | Malmö |
| Website | www.aptahem.com |
| info@aptahem.com | |
| Telephone | +46 (0)766 33 36 99 |
Download the Articles of Association as pdf (in Swedish)